Search Results 1841-1850 of 39061 for Two-phase

  1. A Study Of The Drugs Selumetinib Vs. Carboplatin And Vincristine In Patients With Low-Grade Glioma - Mayo Clinic

    Study phase3 ... There are also less common very early (phase 0) and later (phase 4) phases. ... Patients must have two-dimensional measurable tumor >= 1 cm^2 to be ...

  2. Epicardial Delivery Of XC001 Gene Therapy To Promote Angiogenesis In CAD Patients Undergoing Treatment With CABG - Mayo Clinic

    This is a 26-week (with a 26-week extension) multicenter, randomized, double-blind, placebo-controlled Phase 2 study of XC001 versus placebo. Approximately ...

  3. Effectiveness of Deep Brain Stimulation for Treating People with Treatment Resistant Obsessive-Compulsive Disorder - Mayo Clinic

    Study phase. 2. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase ...

  4. A Multi-center Trial to Evaluate Multiple Regimens in Metastatic Pancreatic Cancer - Mayo Clinic

    Study phase. 3. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase ...

  5. Further Cardiovascular Outcomes Research With PCSK9 Inhibition In Subjects With Elevated Risk - Mayo Clinic

    During the early phases (phases 1 and 2), researchers assess safety, side effects ... Pooled analysis of 5 phase 2 trials included patients with ...

  6. FT819 in Subjects With B-cell Malignancies - Mayo Clinic

    Study phase. 1. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase ...

  7. A Study to Evaluate the Safety and Effectiveness of ALLO-501A CAR T Cell Therapy in Adults with Relapsed/ Refractory Large B Cell Lymphoma - Mayo Clinic

    During the early phases (phases 1 and 2), researchers assess safety ... (Note: Only applicable for Phase 2) For subjects with CLL/SLL: - Diagnosis ...

  8. A Study of the Efficacy and Safety of Risankizumab in Participants With Crohn's Disease - Mayo Clinic

    Study phase. 3. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase ...

  9. Study of Copanlisib in Combination With Standard Immunochemotherapy in Relapsed Indolent Non-Hodgkin's Lymphoma (iNHL) - Mayo Clinic

    There are also less common very early (phase 0) and later (phase 4) phases. ... stage of disease, and previous treatments or health concerns. ... at least 2 months ...

  10. VG161 in the Treatment of Patients With Hepatocellular Carcinoma or Intrahepatic Cholangiocarcinoma - Mayo Clinic

    Overview. Tab Title Description. Study typeInterventional Study phase2. Study ... unresectable HCC, with documented disease progression after at least two lines ...